Glycosylation Pattern and in Vitro Bioactivity of Reference Follitropin Alfa and Biosimilars

Frontiers in Endocrinology - Switzerland
doi 10.3389/fendo.2019.00503
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Frontiers Media SA

Related search

A Prospective Follow-Up on Neonatal Health Following Controlled Ovarian Stimulation With Follitropin Delta or Follitropin Alfa

Fertility and Sterility
GynecologyReproductive MedicineObstetrics
2018English

Adalimumab: A Review of the Reference Product and Biosimilars

Biosimilars
2016English

RE: A Cost-Effectiveness Modeling Evaluation Comparing a Biosimilar Follitropin Alfa Preparation With Its Reference Product for Live Birth Outcome in Germany, Italy and Spain

Journal of Medical Economics
Health Policy
2019English

Managing Infertility With the Follitropin Alfa Prefilled Pen Injector &Ndash; Patient Considerations

Therapeutics and Clinical Risk Management
2015English

The Surface Characterization and Bioactivity of NANOZR in Vitro

Dental Materials Journal
CompositesDentistryCeramics
2014English

Reply: RE: A Cost-Effectiveness Modeling Evaluation Comparing a Biosimilar Follitropin Alfa Preparation With Its Reference Product for Live Birth Outcome in Germany, Italy and Spain

Journal of Medical Economics
Health Policy
2019English

Expression of Cecropin B in Pichia Pastoris and Its Bioactivity in Vitro

Experimental and Therapeutic Medicine
MedicineCancer ResearchImmunologyMicrobiology
2011English

Pmu4 - The Safety of Switching Between Reference Biopharmaceuticals and Biosimilars: A Systematic Review

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Evaluation of PLAGA/n-HA Composite Scaffold Bioactivity in Vitro

Bioceramics Development and Applications
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy